Dr. Vipin Agarwal is President and CEO at NorthEast BioLab. He has extensive experience in the management of bioanalytical laboratories under GCP/GLP environments in the pharmaceutical industry. He has excellent knowledge of state-of-the-art instrumentation (HPLC, LC-MS/MS, automation in sample preparation) and a clear understanding of the role of bioanalyses in the drug development process from discovery to market.
Dr. Agarwal is familiar with various aspects of FDA’s drug development requirements, including submission of Investigational New Drug (IND) and New Drug Application (NDA). Before he founded NorthEast BioLab, Dr. Agarwal was Deputy Director, Bioanalytics at Bayer Pharmaceuticals. He has an MBA from Rensselaer Polytechnic Institute in Troy, NY, and a PhD from the University of New Brunswick in Canada. Dr. Agarwal is an active member of the Journal of Liquid Chromatography & Related Technologies and the American Chemical Society.